Zymeworks Inc. SEC filings ZYME
Zymeworks Inc. has 337 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 29, 2026 | Jun 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Jan 12, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 30, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Nov 18, 2025 | Nov 16, 2025 |
| 8-K |
Current report
Other events
|
Nov 17, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Aug 11, 2025 | Aug 9, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 18, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 21, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 18, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 2, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Other events
|
Jun 10, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Other events
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2024 | Apr 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 8, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 26, 2023 | Dec 23, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 8, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Agreement ended
|
Nov 2, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 16, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Agreement ended, Other events
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 29, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 2, 2023 |
| 8-K |
Current report
Officer or director change
|
May 18, 2023 | May 17, 2023 |
| 8-K |
Current report
Material agreement
|
May 16, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 26, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Other events
|
Apr 18, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Agreement ended
|
Mar 17, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 15, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Other events
|
Jan 19, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Jan 4, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2022 | Dec 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 21, 2022 | Dec 21, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 19, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Other events
|
Dec 19, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Other events
|
Dec 9, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Dec 5, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2022 | Nov 17, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Agreement ended, Other events
|
Oct 28, 2022 | Oct 25, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Oct 21, 2022 | Oct 21, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 19, 2022 | Oct 18, 2022 |
| 8-K |
Current report
Other events
|
Oct 13, 2022 | Oct 13, 2022 |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZYME (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Middletown, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1937653
- Former names
- Zymeworks Delaware Inc. (until Oct 13, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.